对老老鼠的单谷氨基酸诱导的毒性,欧蛋白的保护作用
Gurkan Baytar1, Aslı Okan Oflamaz2, Zuleyha Doganyi̇gi̇t2
1Germencik State Hospital, Aging Health and Care Interdisciplinary Aydin, Turkey.
Neurotoxicology
|November 6, 2025
概括
欧蛋白 (OLE) 通过减少氧化应激和保持器官健康,保护老老鼠免受单谷氨酸 (MSG) 毒性影响. 这表明,富含OLE的食物可以抵消食品添加剂的危害.
科学领域:
- 毒理学 毒理学 毒理学
- 营养科学 营养科学
- 老年学是一门学科.
背景情况:
- 老年有机体对环境毒素的敏感性增加.
- 单谷氨酸 (MSG) 是一种常见的食品添加剂,具有潜在的不良影响.
- 欧蛋白 (OLE) 是一种具有已知的抗氧化特性的天然化合物.
研究的目的:
- 为了研究MSG对老老鼠的毒性影响.
- 评估OLE对MSG诱导毒性的保护潜力.
- 为了分析生化,组织病理和免疫组织化学变化.
主要方法:
- 48只老老鼠被分为控制,MSG,OLE和MSG+OLE组.
- 在28天的时间内口服MSG和OLE.
- 评估生物化学标志物,肝脏/心脏/大脑组织学,以及谷氨酸受体/Kir4.1表达.
主要成果:
- 多样性糖增加了氧化应激 (MDA,NO,TOC) 和肝酶 (ALT,AST),导致肝损伤和神经退行.
- OLE抵消了MSG的影响,减少了氧化损伤并改善了组织完整性.
- MSG改变了心脏中的谷氨酸受体表达;OLE在脑干中使Kir4.1正常化.
结论:
- 在老老鼠中,OLE对MSG毒性表现出显著的肝保护和神经保护作用.
- OLE可以减轻MSG引起的氧化应激,并保护组织结构.
- 研究结果支持富含OLE的食品可以抵消食品添加剂的毒性,这就需要进一步研究分子机制.
相关概念视频
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
213
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
213
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
188
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
188
Anticholinesterase Agents: Poisoning and Treatment
1.5K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.5K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
226
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
226


